Advertisement

Inpharma Weekly

, Volume 1114, Issue 1, pp 13–14 | Cite as

Extrafine CFC-free beclomethasone aerosol hits the right spot

  • Wayne Elwood
Newsletter Article
  • 3 Downloads

Abstract

Inhaled corticosteroids are the gold standard anti-inflammatory therapy for patients with asthma. Currently, only a small proportion of the inhaled corticosteroid dose is actually delivered to the site of inflammation in the airways. Recent moves towards environmentally friendly chlorofluorocarbon (CFC)-free inhaler devices have presented an opportunity to refine, and better target, corticosteroid aerosol delivery to the lungs. The favourable characteristics and clinical potential of a new CFC-free beclomethasone extrafine aerosol were discussed at a 3M-sponsored symposium at the Annual Congress of the European Respiratory Society [ Berlin, Germany; September 1997 ].

Keywords

Beclomethasone Peak Expiratory Flow Rate Lung Deposition European Respiratory Society Local Adverse Effect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1997

Authors and Affiliations

  • Wayne Elwood

There are no affiliations available

Personalised recommendations